Sabra Health Care REIT, Inc.

Questions investors ask about Sabra Health Care REIT

Is Sabra Health Care REIT getting weaker?

Its latest SEC filing (Aug 3, 2026) got weaker in some ways: net margin fell 11.6 points to 7.6%. Its overall score is unchanged at 44/100 since Oct 28, 2026.

How is Sabra Health Care REIT valued vs its peers?

Priced higher than most peers relative to what it earns. Valuation scores 21/100 against 762 real estate peers. EBITDA yield 3.3% vs a peer median of 5.4% (weaker than 75% of peers).EBITDA yield 3.3% vs peers 5.4% (weaker than 75% of peers).

Is Sabra Health Care REIT growing?

At about the same pace as its peers. Growth scores 49/100 against 762 real estate peers. Revenue growth 17.3% vs a peer median of 3.0% (stronger than 82% of peers).Revenue growth 17.3% vs peers 3.0% (stronger than 82% of peers). Earnings per share growth -66.3% vs a peer median of 11.2% (weaker than 94% of peers).Earnings per share growth -66.3% vs peers 11.2% (weaker than 94% of peers).

How profitable is Sabra Health Care REIT?

Less profitable than most of its peers. Profitability scores 23/100 against 762 real estate peers. Return on invested capital 0.6% vs a peer median of 3.4% (weaker than 82% of peers).Return on invested capital 0.6% vs peers 3.4% (weaker than 82% of peers).

How risky is Sabra Health Care REIT?

Lower risk relative to 762 real estate peers, judged on debt, liquidity and share-price swings. Current ratio 3.57× vs a peer median of 1.20× (stronger than 89% of peers).Current ratio 3.57× vs peers 1.20× (stronger than 89% of peers). A relative measure, not a bankruptcy probability.